Events / Videos

7 Oct 2021

Watch the third COG-UK Science Showcase Event – October 2021

Thank you to all the speakers, chairs, attendees and organisers of the COG-UK Anniversary Science Showcase Event.

If you missed the live event, you can watch the full recording here.

Thursday 7th October 2021, 13:00 and 15:30 BST

13.00 – 13.05 Opening remarks – Professor Sharon Peacock, Executive Director and Chair, COG-UK
13.05 – 13.55 Session 1: Hospital and Vaccine Studies: insights from SARS-CoV-2 sequencing – Chair: Dr Thushan de Silva, University of Sheffield
13.05 – 13.20 The COG-UK Hospital Onset Covid Infection (HOCI) study; harnessing pathogen sequencing for infection prevention and control – Professor Judith Breuer, University College London
13.20 – 13.35 Genomic sequencing of SARS-CoV-2 to understand nosocomial spread and the effects of the Pfizer/BioNTech BNT162b2 vaccine in a UK hospital – Kate Cook, University of Portsmouth
13.35 – 13.55 SARS-CoV-2 Genomics in Oxford Vaccine Trials – Dr Tanya Golubchik, University of Oxford; Contributions of Sequencing to the Interpretation of Vaccine Efficacy in the Novavax UK Phase 3 Trial – Dr Joy Rivers, Novavax
13.55 – 14.25  Session 2: Care Home and University Studies: the impact of viral genomics in different settings – Chair: Professor Emma Thomson, University of Glasgow
13.55 – 14.10 COVID-19 in care homes: the challenges and opportunities for genomic sequencing in the VIVALDI study – Dr Maria Krutikov, University College London
14.10 – 14.25 Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission – Dr Dinesh Aggawal, University of Cambridge
BREAK
14.30 – 15.15 Session 3: Public Health and National Infection Surveys: the role played by SARS-CoV-2 genomic data – Chair: Dr Theo Sanderson, Wellcome Sanger Institute/Francis Crick Institute
14.30 – 14.45 SARS-CoV-2 Sequencing in support of the ONS COVID-19 Infection Survey – Dr Katrina Lythgoe, University of Oxford
14.45 – 15.00 SARS-CoV-2 lineage dynamics as inferred from representative community samples – what we can learn from the REACT-1 study – Oliver Eales, Imperial College London
15.00 – 15.15 The role played by COG-UK data in the UKHSA genomics cell – Eileen Gallaghar, UK Health Security Agency
15.15 – 15.20 Thanks and close – Professor Sharon Peacock, Executive Director and Chair, COG-UK

 


COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.